Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson H Miller

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
The Oncologist|April 19, 2002
Molecular targets of arsenic trioxide in malignant cellsWilson H Miller
Journal of Molecular Endocrinology|September 16, 2022
How retinoic acid and arsenic transformed acute promyelocytic leukemia therapyVictoria Korsos, Wilson H Miller
Cancer Cell|April 20, 2004
Death by arsenic: implications of PML sumoylationKoren K Mann, Wilson H Miller
Molecular Cancer Therapeutics|June 21, 2008
Arsenic trioxide decreases AKT protein in a caspase-dependent mannerKoren K Mann, Myrian Colombo, Wilson H Miller
Seminars in Hematology|May 16, 2002
Arsenic trioxide: mechanisms of actionKelly Davison, Koren K Mann, Wilson H Miller
Best Practice & Research. Clinical Haematology|June 8, 2014
Triple A therapy: the molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxideJessica N Nichol, Nicolas Garnier, Wilson H Miller
Molecular and Cellular Biology|January 24, 2008
Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistanceSuzan McNamara, Hongling Wang, Nessrine Hanna, et al.
Expert Opinion on Therapeutic Targets|July 10, 2014
Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyondFilippa Pettersson, Sonia V Del Rincon, Wilson H Miller
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Expanding PML's functional repertoire through post-translational mechanismsJessica N Nichol, Luca A Petruccelli, Wilson H Miller
Blood|July 17, 2004
Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cellsMichael Witcher, Hoi Ying Shiu, Qi Guo, et al.
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
The Oncologist|April 19, 2002
Molecular targets of arsenic trioxide in malignant cellsWilson H Miller
Journal of Molecular Endocrinology|September 16, 2022
How retinoic acid and arsenic transformed acute promyelocytic leukemia therapyVictoria Korsos, Wilson H Miller
Cancer Cell|April 20, 2004
Death by arsenic: implications of PML sumoylationKoren K Mann, Wilson H Miller
Molecular Cancer Therapeutics|June 21, 2008
Arsenic trioxide decreases AKT protein in a caspase-dependent mannerKoren K Mann, Myrian Colombo, Wilson H Miller
Seminars in Hematology|May 16, 2002
Arsenic trioxide: mechanisms of actionKelly Davison, Koren K Mann, Wilson H Miller
Best Practice & Research. Clinical Haematology|June 8, 2014
Triple A therapy: the molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxideJessica N Nichol, Nicolas Garnier, Wilson H Miller
Molecular and Cellular Biology|January 24, 2008
Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistanceSuzan McNamara, Hongling Wang, Nessrine Hanna, et al.
Expert Opinion on Therapeutic Targets|July 10, 2014
Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyondFilippa Pettersson, Sonia V Del Rincon, Wilson H Miller
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Expanding PML's functional repertoire through post-translational mechanismsJessica N Nichol, Luca A Petruccelli, Wilson H Miller
Blood|July 17, 2004
Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cellsMichael Witcher, Hoi Ying Shiu, Qi Guo, et al.
Pageof 17